Herein, GPC4 was reported to be an indispensable downstream effector of CD36 and ectopic GPC4 expression could reverse the tumor suppressive and glycolysis inhibitory functions of CD36 by activating β-catenin/c-myc signaling in CRC cells. Here, MYC is linked to colorectal carcinoma.